Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001204459-08-001190
Filing Date
2008-05-30
Accepted
2008-05-30 12:16:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A nxbl053008sch13d.htm SC 13D/A 36120
  Complete submission text file 0001204459-08-001190.txt   38059
Mailing Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401
Business Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 410 269 2600
PHARMATHENE, INC (Subject) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-80900 | Film No.: 08869311
SIC: 2834 Pharmaceutical Preparations

Mailing Address 70 ST. GEORGE'S CRESCENT EDMONTON A0 T5N 3M7
Business Address 70 ST. GEORGE'S CRESCENT EDMONTON A0 T5N 3M7 780-486-2317
Nexia Biotechnologies Ltd (Filed by) CIK: 0001409726 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0
Type: SC 13D/A